[Dihydroergotamine for treatment of vascular side-effects of thymoleptics (author's transl)].
D000639:Amitriptyline / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D001916:Brachial Artery / Q000503:physiopathology; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy; D004347:Drug Interactions; D004878:Ergotamine / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007024:Hypotension, Orthostatic / Q000139:chemically induced / Q000188:drug therapy*; D007429:Intraocular Pressure; D009880:Ophthalmic Artery / Q000503:physiopathology; D009884:Ophthalmodynamometry; D011187:Posture; D011674:Pulse; D013610:Tachycardia / Q000139:chemically induced* / Q000188:drug therapy*
D000639:Amitriptyline; D004878:Ergotamine
Dihydroergotamin gegen die Kreislaufwirkungen der Thymoleptika